This study investigates the effectiveness and safety of an investigational medication compared to a placebo in treating chronic lung allograft dysfunction (CLAD) in adults who have had a lung transplant. Participants in this study must have had their transplant at least a year ago and must be experiencing progression of …
This study investigates airway inflammation in people aged 40 to 85 with Chronic Obstructive Pulmonary Disease (COPD). The study aims to compare the effects of an investigational medication with a placebo on lung health, including inflammation and mucus buildup, and how these factors relate to lung function and quality of …
This study investigates the effects of an investigational medication compared to a placebo in adults with chronic obstructive pulmonary disease (COPD) that is not well controlled and is characterized by a higher number of eosinophils, a type of white blood cell. The purpose of this study is to assess how …
This study investigates the effects of an investigational medication compared to a placebo in adults with Chronic Obstructive Pulmonary Disease (COPD) that is not well controlled and is characterized by an eosinophilic phenotype. An eosinophilic phenotype refers to a certain type of inflammation in the lungs, which can affect how …
This study investigates the impact of an investigational medication compared to standard care on lung function in adults with uncontrolled moderate to severe asthma. This study aims to determine if the investigational medication can prevent or slow down the decline in lung function.Participants in the study will be randomly assigned …
This study investigates the effectiveness of different investigational medications compared to a placebo in improving lung capacity in participants with Interstitial Lung Disease (ILD) secondary to Systemic Sclerosis (SSc). The purpose is to observe changes from the start to the end of the treatment period at Week 52.Participants in the …
This study investigates the long-term effects of an investigational medication in adults with Alpha-1 Antitrypsin Deficiency (AATD) emphysema. The purpose of this study is to understand how the investigational medication affects individuals with this condition over an extended period.Participants in this study will receive the investigational medication and will be …
